William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
William Blair initiated coverage of Sterling Infrastructure (STRL) with an Outperform rating.Stay Ahead of the Market:Discover outperforming ...
Equities research analysts at William Blair dropped their Q4 2025 EPS estimates for Zumiez in a research report issued on ...
"It is my pleasure to welcome Terence to William Blair’s Healthcare investment banking practice and its biopharma group," said Steve Tole, head of Healthcare investment banking at William Blair. "Our ...
William Blair International Growth Fund earns an Average Process Pillar rating. The most important driver of the rating is the stability of the management team. Specifically, the fund has not seen ...
Research analysts at William Blair boosted their FY2025 EPS estimates for shares of Exelixis in a research report issued on ...
On Wednesday, Lyra Therapeutics Inc (LYRA) stock saw a modest uptick, ending the day at $0.19 which represents no change from the prior close of of $0.19. The stock opened at $0.19 and touched a low ...
William Blair Small Cap Growth Fund earns an Average Process Pillar rating. The leading factor in the rating is the fund's excellent long-term risk-adjusted performance. This can be seen in its ...
Equities researchers at William Blair lifted their FY2024 earnings estimates for Shake Shack in a research report issued to ...